MiHA research deep learning.pdf
•
0 likes•4 views
Creative Biolabs unveils advanced services combining the phage display service with the single-chain minor histocompatibility complexes (SC-MiHC) and Minor Histocompatibility Antigen Display Services. https://allogo.creative-biolabs.com/display-platform.htm
Report
Share
Report
Share
Download to read offline
Recommended
AI-based One-stop Antibody Discovery Platform.pdf
To help our clients develop a safe and effective human antibody, Creative Biolabs is continuously exploring novel AI technologies and phage display libraries for antibody development solutions.
https://ai.creative-biolabs.com/ai-based-one-stop-antibody-discovery-platform.htm
AntInfect™ Platform at Creative Biolabs.pdf
Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs has developed an advanced AntInfect™ Platform which provides various excellent strategies for different purposes.
https://www.creative-biolabs.com/antinfect/antinfect-platform.htm
Background of Therapeutic Non-IgG Antibodies.pdf
Therapeutic antibodies are mainly used for the treatment of cancer and infectious diseases. In addition to the common IgG antibodies, non-IgG antibodies have received more and more attention to the treatment of cancer and infectious diseases in recent years.
https://non-igg-ab.creative-biolabs.com/non-igg-antibody-application-for-disease-therapy.htm
Formats of Bispecific Antibody.pdf
Based on the advanced strategies and to fit the desired the target-product profile, Creative Biolabs can help develop different formats of BsAbs adapted the valency, structure, half-life and biodistribution, etc.
https://www.creative-biolabs.com/bsab/category/custom-bispecific-antibodies-35.htm
Cancer Cells Surface Engineering.pdf
Based on leading-edge facilities and profound knowledge, the seasoned scientific team in Creative Biolabs has developed an integrated CellFace™ conjugate technology platform to bring customers impeccable cancer cell surface engineering.
https://cellface-conjugate.creative-biolabs.com/cancer-cells-surface-engineering-service.htm
Adenovirus Delivery System.pdf
Creative Biolabs provides the state-of-the-art adenoviral vector with the various design and construction to meet the demand in basic research and preclinical applications.
https://www.creative-biolabs.com/gene-therapy/adenovirus-vector.htm
Oncolytic Herpes Simplex Virus.pdf
This document discusses oncolytic viruses, which are viruses that can selectively target and kill cancer cells. It covers the mechanisms of oncolytic viruses, factors to consider in their development like size and pathogenicity, and different families of oncolytic viruses. Specific oncolytic viruses discussed include herpes simplex virus, T-VEC, HF10, and vaccinia virus. The document also examines combination therapies using oncolytic viruses and biomarkers for assessing their delivery and activity in tumor immunotherapy.
AI-Based Antibody Screening.pdf
Creative Biolabs offers a series of AI-based antibody screening services based on the prediction of antibody-antigen binding and a unique way to find rare antibody clusters and get more candidate antibody sequences by augmenting our data-driven AI screening services.
https://ai.creative-biolabs.com/ai-based-antibody-screening-services.htm
Recommended
AI-based One-stop Antibody Discovery Platform.pdf
To help our clients develop a safe and effective human antibody, Creative Biolabs is continuously exploring novel AI technologies and phage display libraries for antibody development solutions.
https://ai.creative-biolabs.com/ai-based-one-stop-antibody-discovery-platform.htm
AntInfect™ Platform at Creative Biolabs.pdf
Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs has developed an advanced AntInfect™ Platform which provides various excellent strategies for different purposes.
https://www.creative-biolabs.com/antinfect/antinfect-platform.htm
Background of Therapeutic Non-IgG Antibodies.pdf
Therapeutic antibodies are mainly used for the treatment of cancer and infectious diseases. In addition to the common IgG antibodies, non-IgG antibodies have received more and more attention to the treatment of cancer and infectious diseases in recent years.
https://non-igg-ab.creative-biolabs.com/non-igg-antibody-application-for-disease-therapy.htm
Formats of Bispecific Antibody.pdf
Based on the advanced strategies and to fit the desired the target-product profile, Creative Biolabs can help develop different formats of BsAbs adapted the valency, structure, half-life and biodistribution, etc.
https://www.creative-biolabs.com/bsab/category/custom-bispecific-antibodies-35.htm
Cancer Cells Surface Engineering.pdf
Based on leading-edge facilities and profound knowledge, the seasoned scientific team in Creative Biolabs has developed an integrated CellFace™ conjugate technology platform to bring customers impeccable cancer cell surface engineering.
https://cellface-conjugate.creative-biolabs.com/cancer-cells-surface-engineering-service.htm
Adenovirus Delivery System.pdf
Creative Biolabs provides the state-of-the-art adenoviral vector with the various design and construction to meet the demand in basic research and preclinical applications.
https://www.creative-biolabs.com/gene-therapy/adenovirus-vector.htm
Oncolytic Herpes Simplex Virus.pdf
This document discusses oncolytic viruses, which are viruses that can selectively target and kill cancer cells. It covers the mechanisms of oncolytic viruses, factors to consider in their development like size and pathogenicity, and different families of oncolytic viruses. Specific oncolytic viruses discussed include herpes simplex virus, T-VEC, HF10, and vaccinia virus. The document also examines combination therapies using oncolytic viruses and biomarkers for assessing their delivery and activity in tumor immunotherapy.
AI-Based Antibody Screening.pdf
Creative Biolabs offers a series of AI-based antibody screening services based on the prediction of antibody-antigen binding and a unique way to find rare antibody clusters and get more candidate antibody sequences by augmenting our data-driven AI screening services.
https://ai.creative-biolabs.com/ai-based-antibody-screening-services.htm
Zika Virus Antibody Discovery.pdf
Creative Biolabs has over a decade of working experience in Anti-Virus Biomolecular Discovery. Based on our advanced AntInfect™ Platform, our seasoned scientists can offer high-quality Zika virus (ZIKV) neutralizing antibody and ZIKV-specific peptide discovery services.
https://www.creative-biolabs.com/antinfect/discovery-of-neutralizing-antibody-nab-and-peptide-targeting-zika-virus.htm
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
With a better understanding of cancer biology and virology, oncolytic virus therapy is becoming a promising treatment modality for tumor targeting and offers unique opportunities for tumor therapy. Taking advantage of our OncoVirapy™ platform, Creative Biolabs can provide high-quality oncolytic virus-based therapy development.
https://www.creative-biolabs.com/oncolytic-virus/introduction-and-mechanism-of-oncolytic-virus-therapy.htm
Gene Editing ZFN, TALEN, and CRISPRCas9.pdf
Creative Biolabs provides Transcription activator-like effector nucleases (TALENs), and CRISPR/Cas (CRISPR associated) systems services to clients all over the world.
https://www.creative-biolabs.com/gene-therapy/gene-editing-for-gene-therapy.htm
AI-augmented Drug Discovery.pdf
Identifying drug targets and candidate sequences is an important process and an unmet challenge in drug development. Creative Biolabs has developed an original AI-augmented drug discovery platform to accelerate drug discovery.
https://ai.creative-biolabs.com/ai-augmented-drug-discovery.htm
Display Platform for MiHC.pdf
Creative Biolabs has developed services combining the phage display service with the single-chain minor histocompatibility complexes (SC-MiHC).
https://allogo.creative-biolabs.com/display-platform.htm
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
This document provides information about Anti-Virus Biomolecular Discovery services from Creative Biolabs for developing antibodies and peptides against infectious diseases. It outlines their platform for membrane protein expression including VLP immunization and DNA immunization. Their technologies include fluorescent cell sorting, hybridoma production of monoclonal antibodies, phage display, and high-density peptide arrays. Their goal is to provide cost-effective discovery of functional antibody and peptide candidates against various virus targets.
Tandem Fab.pdf
Tandem Fabs are a class of Fab-based bispecific antibody fragments. Creative Biolab offers a wide range of Tandem Fab products.
https://www.creative-biolabs.com/bsab/category/tandem-fab-28.htm
Oncolytic Virus Biodistribution Study.pdf
The biodistribution assay of an oncolytic virus is equal to the PK study of a small molecular drug development. Scientists in Creative Biolabs have developed efficient methods to study the biodistribution of oncolytic virus in vivo.
https://www.creative-biolabs.com/oncolytic-virus/oncolytic-virus-biodistribution-study.htm
Recombinant Lentivirus Products.pdf
As a frontier biotech service provider, Creative Biolabs provides superior recombinant lentivirus products for our clients all over the world.
https://www.creative-biolabs.com/gene-therapy/category-recombinant-lentivirus-306.htm
EV Surface Engineering Services.pdf
With years of experience in cell surface conjugation, Creative Biolabs is dedicated to offering high-quality EV engineering services to modulate their function and interactions.
https://cellface-conjugate.creative-biolabs.com/extracellular-vesicles-surface-engineering-service.htm
BsAb Engineering Services.pdf
Creative Biolabs provides BsAb engineering service to adjust the properties of BsAbs such as valency, size, half-life, flexibility, etc., to meet the specific requirements.
https://www.creative-biolabs.com/bsab/bsab-engineering.htm
Discovery of Antibody and Peptide Targeting Escherichia.pdf
Anti-Bacteria Biomolecular Discovery platform at Creative Biolabs, utilizing diverse technologies such as phage display, hybridoma technology, peptide array, etc., provides the best services to facilate the anti-Escherichia projects for global customers.
https://www.creative-biolabs.com/antinfect/discovery-of-antibody-and-peptide-targeting-escherichia.htm
IgD in Autoimmune Diseases.pdf
Immunoglobulin D (IgD) is composed of two identical light chains and two heavy chains. There is increasing evidence that IgD may be involved in the occurrence of some autoimmune diseases.
https://non-igg-ab.creative-biolabs.com/igd-in-autoimmune-diseases.htm
NAA for Autoimmune Disorders.pdf
Autoimmune disorders refer to the diseases caused by abnormally low activity or overactivity of the immune system. It is well known that the immune system is a complex network of special cells and organs that protect the body from germs and other foreign invaders.
https://www.creative-biolabs.com/natural-autoantibody/autoimmune-disorders.htm
AntInfect Platform.pdf
Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs has developed an advanced AntInfect™ Platform which provides various excellent strategies for different purposes.
https://www.creative-biolabs.com/antinfect/antinfect-platform.htm
The Development of Oncolytic Viruses.pdf
Oncolytic herpes simplex virus (oHSV) is one of the oncolytic viruses being studied in cancer therapeutic research and several oHSVs have been investigated in clinical trials.
https://www.creative-biolabs.com/oncolytic-virus/oncolytic-herpes-simplex-virus.htm
Custom Bispecific Antibodies.pdf
Creative Biolabs collects hot therapeutic targets and provides a variety of customized bispecific antibody (BsAb) products.
https://www.creative-biolabs.com/bsab/category/custom-bispecific-antibodies-35.htm
Cell-Covalent Conjugation Service.pdf
Cell surface engineering is one of the most promising solutions to improve therapeutic feasibility and effectiveness. By providing high-quality and customized services, Creative Biolabs is a reliable partner for clients' cell-covalent conjugation requirements.
https://cellface-conjugate.creative-biolabs.com/cell-covalent-conjugation-service.htm
Therapeutic ADCC⁺ Biobetter Antibody Production.pdf
With decades of experience in the field of antibody development, Creative Biolabs is able to provide our clients with the flexibility to adapt to the evolutionary changes in ADCC⁺ antibody development filed.
https://adcc.creative-biolabs.com/adcc-antibody-production.htm
BsAb Sequencing.pdf
Recently, the bispecific antibody (BsAb) has been posited as an attractive cancer therapeutic agent. Creative Biolabs introduces high-precision BsAb sequencing services for fundamental research, clinical diagnostic, and therapeutic industries.
https://www.creative-biolabs.com/bsab/bispecific-antibody-bsab-sequencing.htm
みなさんこんにちはこれ何文字まで入るの？40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの？えこ...
ここ3000字までしか入らないけどタイトルの方がたくさん文字入ると思います。
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
Leonard Jayamohan, Partner & Generative AI Lead, Deloitte
This keynote will reveal how Deloitte leverages Neo4j’s graph power for groundbreaking digital twin solutions, achieving a staggering 100x performance boost. Discover the essential role knowledge graphs play in successful generative AI implementations. Plus, get an exclusive look at an innovative Neo4j + Generative AI solution Deloitte is developing in-house.
More Related Content
More from Candy Swift
Zika Virus Antibody Discovery.pdf
Creative Biolabs has over a decade of working experience in Anti-Virus Biomolecular Discovery. Based on our advanced AntInfect™ Platform, our seasoned scientists can offer high-quality Zika virus (ZIKV) neutralizing antibody and ZIKV-specific peptide discovery services.
https://www.creative-biolabs.com/antinfect/discovery-of-neutralizing-antibody-nab-and-peptide-targeting-zika-virus.htm
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
With a better understanding of cancer biology and virology, oncolytic virus therapy is becoming a promising treatment modality for tumor targeting and offers unique opportunities for tumor therapy. Taking advantage of our OncoVirapy™ platform, Creative Biolabs can provide high-quality oncolytic virus-based therapy development.
https://www.creative-biolabs.com/oncolytic-virus/introduction-and-mechanism-of-oncolytic-virus-therapy.htm
Gene Editing ZFN, TALEN, and CRISPRCas9.pdf
Creative Biolabs provides Transcription activator-like effector nucleases (TALENs), and CRISPR/Cas (CRISPR associated) systems services to clients all over the world.
https://www.creative-biolabs.com/gene-therapy/gene-editing-for-gene-therapy.htm
AI-augmented Drug Discovery.pdf
Identifying drug targets and candidate sequences is an important process and an unmet challenge in drug development. Creative Biolabs has developed an original AI-augmented drug discovery platform to accelerate drug discovery.
https://ai.creative-biolabs.com/ai-augmented-drug-discovery.htm
Display Platform for MiHC.pdf
Creative Biolabs has developed services combining the phage display service with the single-chain minor histocompatibility complexes (SC-MiHC).
https://allogo.creative-biolabs.com/display-platform.htm
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
This document provides information about Anti-Virus Biomolecular Discovery services from Creative Biolabs for developing antibodies and peptides against infectious diseases. It outlines their platform for membrane protein expression including VLP immunization and DNA immunization. Their technologies include fluorescent cell sorting, hybridoma production of monoclonal antibodies, phage display, and high-density peptide arrays. Their goal is to provide cost-effective discovery of functional antibody and peptide candidates against various virus targets.
Tandem Fab.pdf
Tandem Fabs are a class of Fab-based bispecific antibody fragments. Creative Biolab offers a wide range of Tandem Fab products.
https://www.creative-biolabs.com/bsab/category/tandem-fab-28.htm
Oncolytic Virus Biodistribution Study.pdf
The biodistribution assay of an oncolytic virus is equal to the PK study of a small molecular drug development. Scientists in Creative Biolabs have developed efficient methods to study the biodistribution of oncolytic virus in vivo.
https://www.creative-biolabs.com/oncolytic-virus/oncolytic-virus-biodistribution-study.htm
Recombinant Lentivirus Products.pdf
As a frontier biotech service provider, Creative Biolabs provides superior recombinant lentivirus products for our clients all over the world.
https://www.creative-biolabs.com/gene-therapy/category-recombinant-lentivirus-306.htm
EV Surface Engineering Services.pdf
With years of experience in cell surface conjugation, Creative Biolabs is dedicated to offering high-quality EV engineering services to modulate their function and interactions.
https://cellface-conjugate.creative-biolabs.com/extracellular-vesicles-surface-engineering-service.htm
BsAb Engineering Services.pdf
Creative Biolabs provides BsAb engineering service to adjust the properties of BsAbs such as valency, size, half-life, flexibility, etc., to meet the specific requirements.
https://www.creative-biolabs.com/bsab/bsab-engineering.htm
Discovery of Antibody and Peptide Targeting Escherichia.pdf
Anti-Bacteria Biomolecular Discovery platform at Creative Biolabs, utilizing diverse technologies such as phage display, hybridoma technology, peptide array, etc., provides the best services to facilate the anti-Escherichia projects for global customers.
https://www.creative-biolabs.com/antinfect/discovery-of-antibody-and-peptide-targeting-escherichia.htm
IgD in Autoimmune Diseases.pdf
Immunoglobulin D (IgD) is composed of two identical light chains and two heavy chains. There is increasing evidence that IgD may be involved in the occurrence of some autoimmune diseases.
https://non-igg-ab.creative-biolabs.com/igd-in-autoimmune-diseases.htm
NAA for Autoimmune Disorders.pdf
Autoimmune disorders refer to the diseases caused by abnormally low activity or overactivity of the immune system. It is well known that the immune system is a complex network of special cells and organs that protect the body from germs and other foreign invaders.
https://www.creative-biolabs.com/natural-autoantibody/autoimmune-disorders.htm
AntInfect Platform.pdf
Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs has developed an advanced AntInfect™ Platform which provides various excellent strategies for different purposes.
https://www.creative-biolabs.com/antinfect/antinfect-platform.htm
The Development of Oncolytic Viruses.pdf
Oncolytic herpes simplex virus (oHSV) is one of the oncolytic viruses being studied in cancer therapeutic research and several oHSVs have been investigated in clinical trials.
https://www.creative-biolabs.com/oncolytic-virus/oncolytic-herpes-simplex-virus.htm
Custom Bispecific Antibodies.pdf
Creative Biolabs collects hot therapeutic targets and provides a variety of customized bispecific antibody (BsAb) products.
https://www.creative-biolabs.com/bsab/category/custom-bispecific-antibodies-35.htm
Cell-Covalent Conjugation Service.pdf
Cell surface engineering is one of the most promising solutions to improve therapeutic feasibility and effectiveness. By providing high-quality and customized services, Creative Biolabs is a reliable partner for clients' cell-covalent conjugation requirements.
https://cellface-conjugate.creative-biolabs.com/cell-covalent-conjugation-service.htm
Therapeutic ADCC⁺ Biobetter Antibody Production.pdf
With decades of experience in the field of antibody development, Creative Biolabs is able to provide our clients with the flexibility to adapt to the evolutionary changes in ADCC⁺ antibody development filed.
https://adcc.creative-biolabs.com/adcc-antibody-production.htm
BsAb Sequencing.pdf
Recently, the bispecific antibody (BsAb) has been posited as an attractive cancer therapeutic agent. Creative Biolabs introduces high-precision BsAb sequencing services for fundamental research, clinical diagnostic, and therapeutic industries.
https://www.creative-biolabs.com/bsab/bispecific-antibody-bsab-sequencing.htm
More from Candy Swift (20)
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
Discovery of Antibody and Peptide Targeting Escherichia.pdf
Discovery of Antibody and Peptide Targeting Escherichia.pdf
Therapeutic ADCC⁺ Biobetter Antibody Production.pdf
Therapeutic ADCC⁺ Biobetter Antibody Production.pdf
Recently uploaded
みなさんこんにちはこれ何文字まで入るの？40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの？えこ...
ここ3000字までしか入らないけどタイトルの方がたくさん文字入ると思います。
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
Leonard Jayamohan, Partner & Generative AI Lead, Deloitte
This keynote will reveal how Deloitte leverages Neo4j’s graph power for groundbreaking digital twin solutions, achieving a staggering 100x performance boost. Discover the essential role knowledge graphs play in successful generative AI implementations. Plus, get an exclusive look at an innovative Neo4j + Generative AI solution Deloitte is developing in-house.
Climate Impact of Software Testing at Nordic Testing Days
My slides at Nordic Testing Days 6.6.2024
Climate impact / sustainability of software testing discussed on the talk. ICT and testing must carry their part of global responsibility to help with the climat warming. We can minimize the carbon footprint but we can also have a carbon handprint, a positive impact on the climate. Quality characteristics can be added with sustainability, and then measured continuously. Test environments can be used less, and in smaller scale and on demand. Test techniques can be used in optimizing or minimizing number of tests. Test automation can be used to speed up testing.
Mind map of terminologies used in context of Generative AI
Mind map of common terms used in context of Generative AI.
UiPath Test Automation using UiPath Test Suite series, part 5
Welcome to UiPath Test Automation using UiPath Test Suite series part 5. In this session, we will cover CI/CD with devops.
Topics covered:
CI/CD with in UiPath
End-to-end overview of CI/CD pipeline with Azure devops
Speaker:
Lyndsey Byblow, Test Suite Sales Engineer @ UiPath, Inc.
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
Maruthi Prithivirajan, Head of ASEAN & IN Solution Architecture, Neo4j
Get an inside look at the latest Neo4j innovations that enable relationship-driven intelligence at scale. Learn more about the newest cloud integrations and product enhancements that make Neo4j an essential choice for developers building apps with interconnected data and generative AI.
Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...
The choice of an operating system plays a pivotal role in shaping our computing experience. For decades, Microsoft's Windows has dominated the market, offering a familiar and widely adopted platform for personal and professional use. However, as technological advancements continue to push the boundaries of innovation, alternative operating systems have emerged, challenging the status quo and offering users a fresh perspective on computing.
One such alternative that has garnered significant attention and acclaim is Nitrux Linux 3.5.0, a sleek, powerful, and user-friendly Linux distribution that promises to redefine the way we interact with our devices. With its focus on performance, security, and customization, Nitrux Linux presents a compelling case for those seeking to break free from the constraints of proprietary software and embrace the freedom and flexibility of open-source computing.
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
Neha Bajwa, Vice President of Product Marketing, Neo4j
Join us as we explore breakthrough innovations enabled by interconnected data and AI. Discover firsthand how organizations use relationships in data to uncover contextual insights and solve our most pressing challenges – from optimizing supply chains, detecting fraud, and improving customer experiences to accelerating drug discoveries.
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
Imagine a world where machines not only perform tasks but also learn, adapt, and make decisions. This is the promise of Artificial Intelligence (AI), a technology that's not just enhancing our lives but revolutionizing entire industries.
20240607 QFM018 Elixir Reading List May 2024
Everything I found interesting about the Elixir programming ecosystem in May 2024
How to Get CNIC Information System with Paksim Ga.pptx
Pakdata Cf is a groundbreaking system designed to streamline and facilitate access to CNIC information. This innovative platform leverages advanced technology to provide users with efficient and secure access to their CNIC details.
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Discover how MongoDB Atlas and vector search technology can revolutionize your application's search capabilities. This comprehensive presentation covers:
* What is Vector Search?
* Importance and benefits of vector search
* Practical use cases across various industries
* Step-by-step implementation guide
* Live demos with code snippets
* Enhancing LLM capabilities with vector search
* Best practices and optimization strategies
Perfect for developers, AI enthusiasts, and tech leaders. Learn how to leverage MongoDB Atlas to deliver highly relevant, context-aware search results, transforming your data retrieval process. Stay ahead in tech innovation and maximize the potential of your applications.
#MongoDB #VectorSearch #AI #SemanticSearch #TechInnovation #DataScience #LLM #MachineLearning #SearchTechnology
Driving Business Innovation: Latest Generative AI Advancements & Success Story
Are you ready to revolutionize how you handle data? Join us for a webinar where we’ll bring you up to speed with the latest advancements in Generative AI technology and discover how leveraging FME with tools from giants like Google Gemini, Amazon, and Microsoft OpenAI can supercharge your workflow efficiency.
During the hour, we’ll take you through:
Guest Speaker Segment with Hannah Barrington: Dive into the world of dynamic real estate marketing with Hannah, the Marketing Manager at Workspace Group. Hear firsthand how their team generates engaging descriptions for thousands of office units by integrating diverse data sources—from PDF floorplans to web pages—using FME transformers, like OpenAIVisionConnector and AnthropicVisionConnector. This use case will show you how GenAI can streamline content creation for marketing across the board.
Ollama Use Case: Learn how Scenario Specialist Dmitri Bagh has utilized Ollama within FME to input data, create custom models, and enhance security protocols. This segment will include demos to illustrate the full capabilities of FME in AI-driven processes.
Custom AI Models: Discover how to leverage FME to build personalized AI models using your data. Whether it’s populating a model with local data for added security or integrating public AI tools, find out how FME facilitates a versatile and secure approach to AI.
We’ll wrap up with a live Q&A session where you can engage with our experts on your specific use cases, and learn more about optimizing your data workflows with AI.
This webinar is ideal for professionals seeking to harness the power of AI within their data management systems while ensuring high levels of customization and security. Whether you're a novice or an expert, gain actionable insights and strategies to elevate your data processes. Join us to see how FME and AI can revolutionize how you work with data!
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Discover the seamless integration of RPA (Robotic Process Automation), COMPOSER, and APM with AWS IDP enhanced with Slack notifications. Explore how these technologies converge to streamline workflows, optimize performance, and ensure secure access, all while leveraging the power of AWS IDP and real-time communication via Slack notifications.
UiPath Test Automation using UiPath Test Suite series, part 6
Welcome to UiPath Test Automation using UiPath Test Suite series part 6. In this session, we will cover Test Automation with generative AI and Open AI.
UiPath Test Automation with generative AI and Open AI webinar offers an in-depth exploration of leveraging cutting-edge technologies for test automation within the UiPath platform. Attendees will delve into the integration of generative AI, a test automation solution, with Open AI advanced natural language processing capabilities.
Throughout the session, participants will discover how this synergy empowers testers to automate repetitive tasks, enhance testing accuracy, and expedite the software testing life cycle. Topics covered include the seamless integration process, practical use cases, and the benefits of harnessing AI-driven automation for UiPath testing initiatives. By attending this webinar, testers, and automation professionals can gain valuable insights into harnessing the power of AI to optimize their test automation workflows within the UiPath ecosystem, ultimately driving efficiency and quality in software development processes.
What will you get from this session?
1. Insights into integrating generative AI.
2. Understanding how this integration enhances test automation within the UiPath platform
3. Practical demonstrations
4. Exploration of real-world use cases illustrating the benefits of AI-driven test automation for UiPath
Topics covered:
What is generative AI
Test Automation with generative AI and Open AI.
UiPath integration with generative AI
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!
As the digital landscape continually evolves, operating systems play a critical role in shaping user experiences and productivity. The launch of Nitrux Linux 3.5.0 marks a significant milestone, offering a robust alternative to traditional systems such as Windows 11. This article delves into the essence of Nitrux Linux 3.5.0, exploring its unique features, advantages, and how it stands as a compelling choice for both casual users and tech enthusiasts.
“I’m still / I’m still / Chaining from the Block”
“An Outlook of the Ongoing and Future Relationship between Blockchain Technologies and Process-aware Information Systems.” Invited talk at the joint workshop on Blockchain for Information Systems (BC4IS) and Blockchain for Trusted Data Sharing (B4TDS), co-located with with the 36th International Conference on Advanced Information Systems Engineering (CAiSE), 3 June 2024, Limassol, Cyprus.
Video Streaming: Then, Now, and in the Future
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
Recently uploaded (20)
みなさんこんにちはこれ何文字まで入るの？40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの？えこ...
みなさんこんにちはこれ何文字まで入るの？40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの？えこ...
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...
Climate Impact of Software Testing at Nordic Testing Days
Climate Impact of Software Testing at Nordic Testing Days
Mind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AI
UiPath Test Automation using UiPath Test Suite series, part 5
UiPath Test Automation using UiPath Test Suite series, part 5
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...
Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
How to Get CNIC Information System with Paksim Ga.pptx
How to Get CNIC Information System with Paksim Ga.pptx
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Driving Business Innovation: Latest Generative AI Advancements & Success Story
Driving Business Innovation: Latest Generative AI Advancements & Success Story
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!